Analysis of diversity of hepatitis C virus glycoproteins E1 and E2

QR Code

Analysis of diversity of hepatitis C virus glycoproteins E1 and E2

Hepatitis C Virus (HCV) exists as a population of sequence variants that evolves during infection adapting to host pressures. The main targets for the immune response are the envelope glycoproteins E1 and E2, which also mediate viral cell entry. The first hypervariable region (HVR1) of E2, previousl...

Full description

Bibliographic Details
Main Author:	Hudson, Natalia Joanna
Format:	Thesis (University of Nottingham only)
Language:	English
Published:	2012
Subjects:	HCV evolution glycoproteins mouse model transmission acute hepatitis
Online Access:	https://eprints.nottingham.ac.uk/12644/

Similar Items

Immune responses to hepatitis C virus (HCV): investigation of the role of L-ficolin and anti-E1E2
by: Hamed, Mohamed R.
Published: (2009)

Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapy
by: Khera, Tanvi, et al.
Published: (2017)

Production and purification of nipah virus glycoprotein in Spodoptera frugiperda 9 (J.E. Smith) insect cell
by: Sunhare, Raksha
Published: (2013)

Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1
by: Mesalam, Ahmed Atef, et al.
Published: (2018)

High resolution sequencing of hepatitis C virus reveals limited intra-hepatic compartmentalization in end-stage liver disease
by: Hedegaard, Ditte L., et al.
Published: (2017)

Hepatitis C virus quasispecies and pseudotype analysis from acute infection to chronicity in HIV-1 co-infected individuals
by: Ferns, R. Bridget, et al.
Published: (2016)

A Putative Oral Vaccine based on Live Lactococci Expressing the Surface Glycoproteins Respiratory Syncytial Virus.
by: Lim, Erin Swee Hua
Published: (2010)

Production, characterization and scaling up of monoclonal antibodies against neuraminidase glycoprotein of avian influenza virus subtype H9N2
by: Abdelaziz Fadul, Sana Awad
Published: (2011)

Co-infections of hepatitis B patients with other hepatitis viruses and their serological, biological and prognostic markers
by: Hudu Abdullahi, Shuaibu
Published: (2017)

Patients co-infected with hepatitis C virus (HCV) and human immunodeficiency virus recover genotype cross-reactive neutralising antibodies to HCV during antiretroviral therapy
by: Lee, S., et al.
Published: (2014)

Investigation of Hepatitis B virus entry mechanism
by: Raymond, Chidinma
Published: (2022)

Molecular epidemiology and antiviral resistance characterization of Hepatitis C virus circulating in Africa and Brazil
by: Adeboyejo, Kazeem Adeyinka
Published: (2020)

Preventing hepatitis C virus transmission among young people in the justice system
by: Lenton, E., et al.
Published: (2013)

Risk factors for hepatitis c virus infection among adult patients at a public hospital in Kedah, Malaysia
by: Mohd Suan, Mohd Azri
Published: (2019)

Novel entry pathways for Hepatitis B virus
by: Parmar, Devan
Published: (2023)

Inhibition of P-glycoprotein - Mediated Efflux of Digoxinand Its Metabolites by Macrolide Antibiotics
by: Hughes, Jeffery, et al.
Published: (2010)

P-glycoprotein expression in Helicobacter pylori-positive patients: The influence of MDR1 C3435T polymorphism
by: Omar, Marhanis, et al.
Published: (2012)

Effectiveness of an education intervention on Hepatitis C treatment adherence among Libyan patients in a medical center in Tripoli
by: Adam, Samia Ibrahim Mohamed
Published: (2018)

Display of the pres regions of the surface antigen of Hepatitis B virus on M13 and T7 Bactetiophages
by: Kok, Wai Ling
Published: (2001)

Authenticity and Diversity: Enhancing Australian Hepatitis C Prevention Messages
by: Winter, R., et al.
Published: (2013)

Development of anti-hepatitis B virus core antigen biosensor using gold nanoparticle-decorated reduced graphene oxide
by: Abd Muain, Mohamad Farid
Published: (2019)

Development of surface plasmon resonance based assay for simultaneous detection of Hepatitis C and B viral infections
by: Akhavanrezaei, Morvarid
Published: (2015)

Comorbities and medications of patients with chronic hepatitis C under specialist care in the UK
by: Hudson, Benjamin, et al.
Published: (2017)

The cost of treatment failure: resource use and costs incurred by hepatitis C virus genotype 1-infected patients who do or do not achieve sustained virological response to therapy
by: Backx, M., et al.
Published: (2014)

Recombinant hepatitis B virus core particles: association, dissociation and encapsidation of green fluorescent protein.
by: Lee, Khai Wooi, et al.
Published: (2008)

Recombinant human L-ficolin directly neutralizes hepatitis C virus entry
by: Hamed, Mohamed R., et al.
Published: (2014)

The effects of probiotics and symbiotics on risk factors for hepatic encephalopathy
by: Viramontes Hörner, Daniela, et al.
Published: (2017)

Expression, purification and structural characterisation of Hepatitis B virus core antigen with an N-terminal extension
by: Yoon, Kam Yee
Published: (2013)

Detection of Hepatitis B Core Antigen using a Fusion Bacteriophage
by: Hasmoni, Siti Salwa
Published: (2005)

Harm reduction and hepatitis C: On the ethics and politics of prevention and treatment
by: Fraser, S., et al.
Published: (2011)

Hepatitis C treatment - better outcomes through partner support
by: Chapman, Fleur, et al.
Published: (2012)

Evaluation of post infant hepatitis B vaccination among healthy vaccinees and molecular detection of occult hepatitis B among healthy volunteers
by: Shuaibu, Hudu Abdullahi
Published: (2014)

An evaluation of the opt-out approach to Hepatitis C Virus infection testing in prisons
by: Jack, Kathryn
Published: (2020)

Hoxa9 collaborates with E2A-PBX1 in mouse B cell leukemia in association with Flt3 activation and decrease of B cell gene expression
by: Hassawi, Mona, et al.
Published: (2014)

Troubleshooting methods for the generation of novel pseudotyped viruses
by: King, Barnabas, et al.
Published: (2016)

Technical considerations for the generation of novel pseudotyped viruses
by: King, Barnabas, et al.
Published: (2016)

Location of contact residues in pharmacologically distinct drug binding sites on P-glycoprotein
by: Mittra, Rituparna, et al.
Published: (2017)

Protein polysaccharide complexes: permanent/nonpermanent interactions between polysaccharides and polypeptides
by: Gillis, Richard Benjamin
Published: (2015)

Host genetic factors associated with hepatocellular carcinoma in patients with hepatitis C virus infection: a systematic review
by: Walker, Alex J., et al.
Published: (2018)

c-Met inhibition in aHOXA9/Meis1model of CN-AML
by: Mulgrew, Nuala M., et al.
Published: (2013)